Press Releases

Date Title View
Toggle Summary Second Sight Announces Pricing of Initial Public Offering
SYLMAR, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. ("Second Sight") today announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual
View HTML
Toggle Summary Second Sight Argus® II Retinal Prosthesis System to be trialled in blind dry AMD patients for the first time
Five blind patients with AMD will receive groundbreaking Argus II 'bionic eye' treatment at Manchester Royal Eye Hospital
View HTML
Toggle Summary Second Sight Argus® II Retinal Prosthesis System wins financial support agreement in France View HTML
Toggle Summary Second Sight Argus® II Retinal Prosthesis System is granted innovation funding by the French Ministry of Social Affairs and Health View HTML
Toggle Summary Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System In the United States
Argus® II is the first approved bionic eye in the U.S. for the treatment of blindness due to Retinitis Pigmentosa
View HTML
Toggle Summary MD+DI, the Global MedTech Industry Authority, Announces the 2013 Medical Device Manufacturer of the Year View HTML
Toggle Summary NHS England to consider reimbursing “bionic eye” treatment for blindness caused by retinitis pigmentosa View HTML
Toggle Summary CMS Approves New Technology Add-on Payment and Pass-Through Payment for the Argus® II Retinal Prosthesis System
Payments May Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings
View HTML
Toggle Summary Second Sight Medical Products Receives FDA Approval for Argus II System
Argus® II Retinal Prosthesis System is the first approved bionic eye in the US with life-changing potential for the treatment of blindness due to retinitis pigmentosa
View HTML
Toggle Summary FDA Panel Recommends FDA Approval for Second Sight’s Argus® II Retinal Prosthesis System View HTML